Registered Nurse, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Nurse Educator, St Vincent's Hospital, Sydney, New South Wales, Australia.
Br J Nurs. 2021 Feb 11;30(3):178-183. doi: 10.12968/bjon.2021.30.3.178.
Lung transplantation is a well-established treatment for a variety of end-stage pulmonary diseases. However, the journey of a lung transplant recipient is complex and multifaceted. Silicosis is a rare indication for lung transplantation, but no other treatment is yet available for this disease in its end stages. This Australian case study presents a 52-year-old man with silicosis who received bilateral lung transplantation. The patient was frequently noncompliant with noninvasive ventilation therapy and experienced the complication of type 2 respiratory failure. Patient education and support provided, particularly around medication management following transplantation surgery, are discussed here. The patient's social situation and its implications for both him and his family are also considered.
肺移植是治疗各种终末期肺部疾病的一种成熟治疗方法。然而，肺移植受者的旅程是复杂和多方面的。矽肺是肺移植的一个罕见指征，但在疾病的终末期，还没有其他治疗方法。本澳大利亚病例研究介绍了一位 52 岁的矽肺患者，他接受了双侧肺移植。该患者经常不遵守无创通气治疗，并出现 2 型呼吸衰竭的并发症。本文讨论了对该患者的教育和支持，特别是在移植手术后的药物管理方面。还考虑了患者的社会状况及其对他和他的家庭的影响。
